Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via REUTERS)
The European Union’s drug regulator said on Monday it could issue “within weeks” a decision on whether to approve the use of Pfizer’s COVID-19 pill, Paxlovid, after the U.S. drugmaker submitted an application seeking authorization.
The approval sought is for the treatment of mild-to-moderate COVID 19 in patients 12 years of age and older, weighing at least 40 kilograms and are at high risk of their illness worsening, the European Medicines Agency said.
MOST READ
LATEST STORIES